Earnings (Loss) Per Share (Tables)	9 Months Ended
Mar. 31, 2026
Earnings (Loss) Per Share [Abstract]
Income From Continuing Operations And Share Data Used In Basic And Diluted Earnings Per Share Computations	Three months ended Nine months ended March 31, March 31, 2026 2025 2026 2025 (in thousands except (in thousands except percent and percent and per share data) per share data) Numerator: Net earnings (loss) attributable to Lesaka (A) $ 552 $ (22,353) $ (461) $ (59,659) Undistributed Earnings (Loss) (A) 552 (22,353) (461) (59,659) Percent allocated to common shareholders (Calculation 1) 97% 96% 97% 96% Numerator for earnings (loss) per share: basic and diluted $ 535 $ (21,546) $ (446) $ (57,507) Denominator Denominator for basic earnings (loss) per share: Weighted-average common shares outstanding 79,300 78,347 78,895 69,724 Effect of dilutive securities: Stock options 179 - - - Denominator for diluted earnings (loss) per share: adjusted weighted average common shares outstanding and assuming conversion 79,479 78,347 78,895 69,724 Earnings (Loss) per share: Basic (A) $ 0.01 $ (0.28) $ (0.01) $ (0.82) Diluted (A) $ 0.01 $ (0.28) $ (0.01) $ (0.82) (Calculation 1) Basic weighted-average common shares outstanding (A) 79,300 78,347 78,895 69,724 Basic weighted-average common shares outstanding and unvested restricted shares expected to vest (B) 81,845 81,282 81,464 72,333 Percent allocated to common shareholders (A) / (B) 97% 96% 97% 96% (A) Net loss attributable to Lesaka and Undistributed loss for the three and nine months ended March 31, 2025, have decreased by $ 0.3 million and $ 0.9 million, respectively, as a result of the correction discussed in Note 1. Net loss attributable to Lesaka and Undistributed loss for the nine months ended March 31, 2026, has decreased by $ 0.4 million, as a result of the correction, as discussed in Note 1, to the amount included in the captions Net loss attributable to Lesaka and Undistributed loss for the three months ended September 30, 2025. The correction of the error did not impact Basic and Diluted loss per share for the three months ended March 31, 2025, or the nine months ended March 31, 2026. Basic and Diluted loss per share for the nine months ended March 31, 2025, each decreased by $ 0.01 (one U.S. cent).

Three months ended

Nine months ended

March 31,

2026

2025

2026

2025

(in thousands except

percent and

per share data)

Numerator:

Net earnings (loss) attributable to Lesaka

(A)

552

(22,353)

(461)

(59,659)

Undistributed Earnings (Loss)

(A)

552

(22,353)

(461)

(59,659)

Percent allocated to common shareholders

(Calculation 1)

97%

96%

97%

96%

Numerator for earnings (loss) per share: basic

and diluted

535

(21,546)

(446)

(57,507)

Denominator

Denominator for basic earnings (loss) per share:

Weighted-average

common shares outstanding

79,300

78,347

78,895

69,724

Effect of dilutive securities:

Stock options

179

Denominator for diluted earnings (loss)

per share: adjusted weighted average

common shares outstanding and assuming

conversion

79,479

78,347

78,895

69,724

Earnings (Loss) per share:

Basic

(A)

0.01

(0.28)

(0.01)

(0.82)

Diluted

(A)

0.01

(0.28)

(0.01)

(0.82)

(Calculation 1)

Basic weighted-average common shares

outstanding (A)

79,300

78,347

78,895

69,724

Basic weighted-average common shares

outstanding and unvested restricted shares

expected to vest (B)

81,845

81,282

81,464

72,333

Percent allocated to common shareholders

(A) / (B)

97%

96%

97%

96%

(A) Net loss attributable to

Lesaka and Undistributed

loss for the three and nine

months ended March 31, 2025,

have decreased

by $

0.3

million and

0.9

million, respectively,

as a

result of

the correction

discussed in

Note 1.

Net loss

attributable to

Lesaka and

Undistributed loss for the nine months ended March 31,

2026, has decreased by $

0.4

million, as a result of the correction,

as discussed

in Note

1, to

the amount

included in

the captions

Net loss

attributable to

Lesaka and

Undistributed loss

for the

three months

ended

September 30, 2025. The correction of the error did not impact Basic and Diluted loss per share for the three months ended March 31,

2025,

or the

nine months

ended March

31, 2026.

Basic and Diluted

loss per

share for

the nine months

ended March

31, 2025,

each

decreased by $

0.01

(one U.S. cent).